<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO> AP890510-0066 </DOCNO><FILEID>AP-NR-05-10-89 0633EST</FILEID><FIRST>r a PM-FDA-Corruption     05-10 0273</FIRST><SECOND>PM-FDA-Corruption,0281</SECOND><HEAD>More Charges Filed In Food And Drug Administration Corruption Case</HEAD><DATELINE>BALTIMORE (AP) </DATELINE><TEXT>   A former official of the FDA's generic drugsdivision has been charged with allegedly accepting a free trip toHong Kong and furniture as bribes from a New York state drugmanufacturer.   Charles Y. Chang, a former branch chief in the Food and DrugAdminstration's Division of Generic Drugs, was charged Tuesday inU.S. District Court with two counts of interstate travel in aid ofracketeering. Each charge carries a maximum penalty of five yearsin prison and a $250,000 fine upon conviction.   Chang is accused of taking bribes from American TherapeuticsInc., a generic drug manufacturer, said U.S. Attorney BreckinridgeL. Willcox. The Bohemia, N.Y., drug manufacturer has not beencharged.   Chang is the third person and the second FDA chemist to becharged in the wide-ranging investigation of alleged bribery in thegeneric drugs division.   Chang accepted a free trip from his Potomac residence to HongKong from the company in July 1987 and accepted chairs, lamps, bedsand other furniture from the company in September 1987, authoritiessaid.   In late April, Chang was named but not charged in a criminalinformation as the recipient of a $2,000 cash gratuity from anexecutive of a Colorado-based generic drug company.   The division is responsible for reviewing applications submittedby pharmaceutical manufacturers seeking to market generic drugs.Chang supervised chemists who reviewed the applications.   The investigation, which began last summer, is being conductedby the U.S. Attorney's office, the Inspector General of the U.S.Health and Human Services Department, and the U.S. House Energy andCommerce Committee.</TEXT></DOC>